Dimenoxadol
From Wikipedia, the free encyclopedia
Dimenoxadol
|
|
Systematic (IUPAC) name | |
2-dimethylaminoethyl 2-ethoxy-2,2-di(phenyl)acetate | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C20H25NO3 |
Mol. mass | 327.42 g/mol |
SMILES | & |
Synonyms | Dimenoxadol, Estocin |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Dimenoxadol (Estocin) is an opioid analgesic which is a diphenylacetic acid derivative, related to other drugs such as dextropropoxyphene.
It was invented in Russia in the 1960s, and produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.[1][2]
[edit] References
- ^ Gorbatova EN. The pharmacology of estocin, a new analgesic. (Russian). Stomatologiia (Moskow). 1967 Mar-Apr;46(2):22-5.
- ^ Kingisepp GIa, Kurvits KhKh, Nurmand LB. Pharmacology of dimethylaminoethyl ester of diphenylethoxyacetic acid hydrochloride--estocin. (Russian) Farmakologiia i Toksikologiia. 1969 Nov-Dec;32(6):710-2.